Skip to main content
. Author manuscript; available in PMC: 2021 May 20.
Published in final edited form as: Neuron. 2020 Mar 18;106(4):624–636.e4. doi: 10.1016/j.neuron.2020.02.029

FIGURE 1. RMTgGABA→VTA synapses exhibit LTD even in DAMGO.

FIGURE 1.

A. Representative viral injection in the RMTg, horizontal section. See Figure S1A for all localizations. B. Representative experiment, LTD of olPSCs in a cell is induced by oLFS of RMTg GABAergic afferents. Blue bars indicate time of oLFS. In this and all other electrophysiological experiments,DNQX/strychnine were included in the bath solution except as noted. C. Representative similar experiment in the presence of the NMDAR antagonist, d-APV. Insets: olPSCs during baseline (black) and 10–20 min after oLFS (red). D. Time course of LTD; averaged olPSC amplitudes before and after oLFS (n = 13 cells). E. Mean olPSC amplitudes for each cell comparing a 10 min baseline period and a period from 10–20 min after oLFS (p = 0.018, paired t-test). In all subsequent figures, d-APV was included in the bath solution. F. Representative experiment, 1 μM DAMGO bath application depresses olPSCs; 2 μM naloxone reverses this. G. Mean olPSC amplitudes before and in DAMGO (p < 0.0001, paired t-test) (n = 11 cells). H. Representative experiment, oLFS induces LTD in 1 μM DAMGO. I. Time course of averaged olPSC amplitudes for each cell before and after oLFS in 1 μM DAMGO (n = 8 cells/mice), and J. mean olPSC amplitudes during a 10 min baseline and 10–20 min after oLFS in DAMGO (p = 0.03, paired t-test). Data are represented as mean ± SEM. Calibrations: 100 pA, 20 ms. *p < .05, paired t-test of amplitude of 10 min baseline vs.10–20 min after oLFS. See also related Supplemental Figure 1.